132 related articles for article (PubMed ID: 37960876)
21. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
[TBL] [Abstract][Full Text] [Related]
22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
23. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
24. Serum microRNA expression profiling revealing potential diagnostic biomarkers for lung adenocarcinoma.
Shan X; Zhang L; Zhu DX; Zhou X; Zhang H; Liu QX; Tang JW; Wen W; Wang TS; Zhu W; Liu P
Chin Med J (Engl); 2020 Nov; 133(21):2532-2542. PubMed ID: 32947363
[TBL] [Abstract][Full Text] [Related]
25. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis.
Zhou X; Wen W; Shan X; Zhu W; Xu J; Guo R; Cheng W; Wang F; Qi LW; Chen Y; Huang Z; Wang T; Zhu D; Liu P; Shu Y
Oncotarget; 2017 Jan; 8(4):6513-6525. PubMed ID: 28036284
[TBL] [Abstract][Full Text] [Related]
26. Breast invasive ductal carcinoma diagnosis with a three-miRNA panel in serum.
Chen X; Li X; Wang J; Zhao L; Peng X; Zhang C; Liu K; Huang G; Lai Y
Biomark Med; 2021 Aug; 15(12):951-963. PubMed ID: 34293926
[No Abstract] [Full Text] [Related]
27. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
28. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
29. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y
Biomarkers; 2024 May; ():1-9. PubMed ID: 38767408
[TBL] [Abstract][Full Text] [Related]
30. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
Zhao Y; Lu C; Zhu R; Hu X
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
[TBL] [Abstract][Full Text] [Related]
31. Bladder cancer diagnosis with a four-miRNA panel in serum.
Li X; Chen W; Li R; Chen X; Huang G; Lu C; Wen Z; Peng X; Liu K; Zhang C; Li H; Hu Y; Zhao Z; Tao L; Lai Y
Future Oncol; 2022 Sep; 18(29):3311-3322. PubMed ID: 36047424
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer.
Zhang S; Liu C; Zou X; Geng X; Zhou X; Fan X; Zhu D; Zhang H; Zhu W
PeerJ; 2021; 9():e11441. PubMed ID: 34055487
[TBL] [Abstract][Full Text] [Related]
33. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
Yong FL; Law CW; Wang CW
BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
[TBL] [Abstract][Full Text] [Related]
34. Identification of miRNA signatures and their therapeutic potentials in prostate cancer.
Karadag A; Ozen A; Ozkurt M; Can C; Bozgeyik I; Kabadere S; Uyar R
Mol Biol Rep; 2021 Jul; 48(7):5531-5539. PubMed ID: 34318435
[TBL] [Abstract][Full Text] [Related]
35. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
36. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
37. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
[TBL] [Abstract][Full Text] [Related]
38. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
39. Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma.
Zheng G; Du L; Yang X; Zhang X; Wang L; Yang Y; Li J; Wang C
Br J Cancer; 2014 Nov; 111(10):1985-92. PubMed ID: 25233400
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
